ArticleRedox biology2021

Corrigendum to 'A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients'. [Redox Biology 45 (2021) 102037].

Cláudia M Deus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.